Dr. Kevin B. Kim, MD

Dr. Kim practices at San Francisco Plastic Surgery Center in San Francisco, California.

Dr. Kim's NPI, 1851485056, was assigned on October 3, 2006. Dr. Kim graduated from University of Illinois College of Medicine - Chicago in 1995. Dr. Kim's Texas license number on file is L4495.

Dr. Kim's primary practice is San Francisco Plastic Surgery Center, at 2100 Webster St Ste 506, San Francisco, CA 94115. The practice phone is (415) 923-3067.

Dr. Kim's primary practice is San Francisco Plastic Surgery Center in San Francisco, California. Dr. Kim is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is San Francisco Oncology Associates. Dmand AI also links Dr. Kim to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Kim's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kim is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Kim's licenses on file in 3 states: Texas, California and Minnesota.

Dmand AI lists colorectal cancer, lung cancer and lymphoma among the conditions Dr. Kim treats.

CMS data shows 38,528 Medicare services from Dr. Kim across 13 procedure codes in 2024, for 239 Medicare patients. Medicare paid $1,413,738 for them. Every service was in an office.

CMS counts 239 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 112 patients. 68% of them have high blood pressure, and 67% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 75, with 40% women.

In 2024, Dr. Kim wrote 622 Medicare Part D claims for 84 patients. 64% of them were for generic drugs. CMS names the drug for 434 of them, across 15 drugs with 11 or more claims each, at $1,542,141 in total drug cost. In 2023, CMS named 359 claims across 16 drugs.

Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Dmand AI links 80 papers to Dr. Kim, published from 2008 to 2024. 2017 was the busiest year, with 4. The most frequent topics are Melanoma, Skin Neoplasms and Proto-Oncogene Proteins B-raf. Dr. Kim has published most often in Melanoma Res. Dr. Kim's most frequent co-authors are Agop Y. Bedikian, MD, Nicholas E. Papadopoulos, MD and Wen-Jen Hwu, MD.

CMS Open Payments shows 812 general payments to Dr. Kim from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Bristol-Myers Squibb Company paid the most, $135,161. It also lists 44 research payments totaling $10,563 from 2022 to 2025, naming 1 clinical trial.

Dr. Kim graduated from University of Illinois College of Medicine - Chicago in 1995.

Dr. Kim is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.